Collaborative deprescribing intervention of Proton-Pump Inhibitors among community-dwelling older adults: The C-SENIoR trial
Not Applicable
- Conditions
- Overprescribing of proton-pump inhibitorsNot Applicable
- Registration Number
- ISRCTN49637686
- Lead Sponsor
- ational Association of Pharmacies
- Brief Summary
2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38530823/ (added 27/03/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 222
Inclusion Criteria
1. Community-dwelling older adults, aged 65 years old or over
2. Continuous use for more than 8 weeks of any PPI (ATC/WHO A02BC– esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole)
3. Registered at the selected Family Health Units
4. Access to a telephone
Exclusion Criteria
1. Live in nursing homes or assisted-living facilities
2. Unable to communicate or speak in Portuguese
3. Have any cognitive impairment or any other condition that does not allow them to understand the study objectives or the questionnaire completion as perceived by the pharmacist.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method